Skip to main content

August 2015

 

 

academics

 

Clinical research courses

Career for Pharmacists (345 posts) @ JRHMS

Applications are invited for varios positions from eligible candidates under NRHM

Post: Pharmacist- RBSK

Vacancies for Pharmacist (14 Posts) in Office of the CDMO: Subarnapur

Applications in the prescribed proforma are invited from eligible candidates for the post of Pharmacist under the Chief District Medical Officer, Subarnapur to be filled up on contractual basis.

Post: Pharmacist

Opening for Project Fellow (PA II) in National Chemical Laboratory

Applications are invited on plain paper for filling up of position of Project Fellow (PA II) on a purely temporary basis, in the prescribed proforma. The details of the Sponsored Project under which engagement is proposed to be made is as under :

Post: Project Fellow (PA II) - One

Researchers discovered that ethoxzolamide, a sulfa-based compound found in many prescription glaucoma drugs, actually turns off the bacterium's ability to invade the immune system.  In a breakthrough discovery, Robert Abramovitch, a Michigan State University microbiologist, along with a graduate student have suggested that a common medication used to treat glaucoma could also be used to treat tuberculosis (TB). The study has been published in Antimicrobial Agents and Chemotherapy.

A study conducted at the University of Colorado Boulder suggest even a placebo with no medical value can ease pain in research participants. The study found in The Journal of Pain.

(adsbygoogle = window.adsbygoogle || []).push({});

Apollo Children’s Hospital has recently performed surgeries on children using the da Vinci robot. Robotic procedures have proven to be highly precise and targeted. This technique provides advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.

Prior studies suggesting that diabetes drug 'Actos' might raise users' risk of bladder cancer but  new study found no evidence for such an effect. Instead, researchers found a link between the use of Actos (pioglitazone) and a rise in pancreatic cancer risk, but experts say it's too early to draw any conclusive link. The study is published in Journal of the American Medical Association.